Long-Term Outcomes of Patients With BRCA+ or PALB2+ Pancreatic Cancer Treated With Maintenance Rucaparib
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性,不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1001/jamaoncol.2026.0870
文献链接: https://jamanetwork.com/journals/jamaoncology/fullarticle/2848248
其他信息:
出版社: American Medical Association (AMA)
作者: Kim A. Reiss; Mingyi Xia; Mwangala Akamandisa; Kurt D’Andrea; Brad Wubbenhorst; Christopher J. Lord; Stephen J. Pettitt; Andrew N. J. Tutt; Timothy J. Brown; Mark H. O’Hara; Charles Schneider; Ursina Teitelbaum; Zain Hannan; Ryan Hood; Rashmi Tondon; Robert H. Vonderheide; Susan M. Domchek; Katherine L. Nathanson

